DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/c529af/prostate_cancer_pa) has announced the addition of the "Prostate Cancer Partnering 2007-2012" report to their offering.
The Prostate Cancer Partnering 2007-2012 provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of prostate cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors prostate cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
This data driven report contains over 160 links to online copies of actual prostate cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in prostate cancer partnering
Chapter 3 - Leading prostate cancer deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
Appendices
For more information visit http://www.researchandmarkets.com/research/c529af/prostate_cancer_pa